or Try an Advanced Search...

    Technical Analysis for QNTM - Quantum Biopharma Ltd.

    Grade Last Price % Change Price Change
    F 4.20 4.48% 0.18
    QNTM closed down 1.47 percent on Thursday, September 19, 2024, on 4 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical QNTM trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 4.48%
    NR7 Range Contraction 4.48%
    Narrow Range Bar Range Contraction 4.48%
    Inside Day Range Contraction 4.48%
    Wide Bands Range Expansion 4.48%
    Fell Below 20 DMA Bearish 2.94%
    Outside Day Range Expansion 2.94%
    Wide Bands Range Expansion 2.94%
    Crossed Above 20 DMA Bullish 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Older End-of-Day Signals for QNTM ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 20 DMA 43 minutes ago
    10 DMA Support 43 minutes ago
    60 Minute Opening Range Breakout 43 minutes ago
    Rose Above Previous Day's High 43 minutes ago
    Outside Day 43 minutes ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    QNTM Chart by TradingView
    Basic chart:

    Profile

    Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Biotechnology Lucid

    Is QNTM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 14 Quantum BioPharma Closes Private Placement Offering
    Sep 9 Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis
    Sep 9 Quantum Biopharma regains Nasdaq compliance
    Sep 6 Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements
    Aug 30 Quantum BioPharma Ltd. (QNTM) Announces Key Milestones; Price Target $12.80
    Aug 30 Quantum Biopharma Announces Celly Nutrition Launches unbuzzd(TM) Grab-and-Go Stick Packs on Amazon.com so you can "own NOW and what’s NEXT"
    Aug 23 Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update
    Aug 15 FSD Pharma Completes Name Change to Quantum BioPharma and 65:1 Consolidation - Trading Under New Ticker Symbol "QNTM"
    Aug 10 FSD Pharma Announces Share Consolidation and Name Change
    Aug 9 US Stocks Edge Lower; EchoStar Shares Tumble After Q2 Results
    See more QNTM news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 97.5
    52 Week Low 3.5007
    Average Volume 627,335
    200-Day Moving Average 32.31
    50-Day Moving Average 6.11
    20-Day Moving Average 4.15
    10-Day Moving Average 4.00
    Average True Range 0.79
    RSI (14) 41.52
    ADX 21.84
    +DI 18.54
    -DI 17.48
    Chandelier Exit (Long, 3 ATRs) 2.98
    Chandelier Exit (Short, 3 ATRs) 5.87
    Upper Bollinger Bands 4.79
    Lower Bollinger Band 3.50
    Percent B (%b) 0.4
    BandWidth 31.12
    MACD Line -0.61
    MACD Signal Line -0.80
    MACD Histogram 0.1839
    Fundamentals Value
    Market Cap 158.29 Million
    Num Shares 39.4 Million
    EPS -0.58
    Price-to-Earnings (P/E) Ratio -6.93
    Price-to-Sales 91.86
    Price-to-Book 2.28
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.23
    Resistance 3 (R3) 4.25 4.19 4.19
    Resistance 2 (R2) 4.19 4.14 4.18 4.18
    Resistance 1 (R1) 4.11 4.11 4.08 4.09 4.17
    Pivot Point 4.05 4.05 4.04 4.04 4.05
    Support 1 (S1) 3.97 4.00 3.94 3.95 3.87
    Support 2 (S2) 3.91 3.97 3.91 3.86
    Support 3 (S3) 3.83 3.91 3.85
    Support 4 (S4) 3.81